The treatment for pancreatic inflammation has been shown in the lab to prevent COVID-19 from entering human cells
News
Roche begins trial of Actemra/RoActemra plus remdesivir
The trial will test the potential of combining an antiviral with an immune modulator
MSD’s Keytruda doubles PFS in bowel cancer subset
The ‘game-changing’ results will likely result in a paradigm shift in current clinical practice, researchers said
PureTech advances experimental COVID-19 drug into global trials
LYT-100 employs a multimodal mechanism of action to potentially reduce, delay or prevent the lung dysfunction documented in COVID-19 patients
Researchers develop AI tool able to predict cancer relapse
Researchers are hopeful that this ‘ground-breaking approach’ could accelerate the prediction of which patients are more at risk of their disease returning
NICE u-turn backs Roche’s Tecentriq for small-cell lung cancer
The drug giant agreed a new price for Tecentriq with NHS England and Improvement
Government launches coronavirus test and trace service
Anyone who tests positive for coronavirus will be contacted by NHS Test and Trace and will need to share information about their recent interactions
Novo Nordisk launches social responsibility strategy for diabetes
The Defeat Diabetes includes a number of initiatives to provide access to affordable care to vulnerable patients and accelerate prevention to halt the rise of the disease
New analysis shows survival benefit of Novartis’ Kisqali
In patients with liver metastases, Kisqali combination therapy cut the risk of death by 47% and 37% in two trials
NICE issues final guidance on NHS use of Bayer’s Vitrakvi
Evidence from trials suggests that tumours with NTRK gene fusions shrink in response to larotrectinib
MSD unveils bid to tackle coronavirus pandemic
The group will work on two experimental vaccines and an antiviral
NHS patients to be given experimental coronavirus therapy remdesivir
The drug will be provided to the NHS free of charge by Gilead via the UK’s early access to medicines scheme
Novavax launches trial of coronavirus vaccine candidate
The firm has begun enrolling patients in the Phase I portion of the trial
New US approval for Takeda’s Alunbrig
The move is based on data showing Alunbrig’s superiority over crizotinib as first-line treatment of metastatic ALK+ NSCLC
Sanofi to sell stake in Regeneron
The move does not affect the firms’ ongoing collaboration
